A non-ligand surrogate agonist antibody that enhances canonical Wnt signaling and bone regeneration
Lee, N.-K.; Bidlingmaier, S.; Su, Y.; Seo, Y.; Liu, B.
Show abstract
The Wnt signaling pathway promotes tissue regeneration and is a promising therapeutic target for treatment of osteolytic bone diseases. Here we report the discovery of a novel type of canonical Wnt agonist antibody that does not operate as a ligand surrogate. The antibody increases Wnt/{beta}-catenin signaling with or without exogenously provided Wnt ligands. It binds to a site on the P3 domain of LRP6 that is distinct from where the Wnt3a ligand and the DKK1 antagonist bind. The agonist effect persists in the presence of DKK1 and is further amplified by R-spondin even when Wnt ligands are not provided, suggesting a potential use for this antibody in ligand-low or insufficient settings. The antibody induces osteoblastic differentiation and mineralization in vitro and restores bone loss in vivo in a myeloma-derived intrafemoral mouse model, opening a potential path for therapeutic development in osteolytic diseases caused by cancer and aging.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Peroxiredoxin 5 regulates osteogenic differentiation via interaction with hnRNPK during bone regeneration 96%
- Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signaling 95%
- MicroRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling 95%
Similar papers in this journal
- NGF-p75 signaling coordinates skeletal cell migration during bone repair 94%
- The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts 93%
- Frizzled BRET sensors based on bioorthogonal labeling of unnatural amino acids reveal WNT-induced dynamics of the cysteine-rich domain. 93%
Similar papers in this journal
- Proteomic analysis identifies the E3 ubiquitin ligase Pdzrn3 as a regulatory target of Wnt5a-Ror signaling 94%
- Variants in the SOX9 transactivation middle domain induce axial skeleton dysplasia and scoliosis 93%
- Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for co-receptor discrimination 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.